For the quarter ended September 2025, Becton Dickinson (BDX) reported revenue of $5.89 billion, up 8.3% over the same period last year. EPS came in at $3.96, compared to $3.81 in the year-ago quarter.
Surgeons in the United States have historically treated glenohumeral osteoarthritis in younger, active patients with either ...